1. Home
  2. CIX vs RCKT Comparison

CIX vs RCKT Comparison

Compare CIX & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CompX International Inc.

CIX

CompX International Inc.

HOLD

Current Price

$37.12

Market Cap

387.0M

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.71

Market Cap

394.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIX
RCKT
Founded
1993
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
387.0M
394.2M
IPO Year
1997
2014

Fundamental Metrics

Financial Performance
Metric
CIX
RCKT
Price
$37.12
$3.71
Analyst Decision
Buy
Analyst Count
0
14
Target Price
N/A
$29.73
AVG Volume (30 Days)
7.2K
1.3M
Earning Date
05-05-2026
05-04-2026
Dividend Yield
9.48%
N/A
EPS Growth
17.04
26.37
EPS
1.06
0.66
Revenue
$158,285,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$64.28
P/E Ratio
$33.02
$5.87
Revenue Growth
8.46
N/A
52 Week Low
$20.29
$2.53
52 Week High
$36.25
$5.45

Technical Indicators

Market Signals
Indicator
CIX
RCKT
Relative Strength Index (RSI) 80.67 54.59
Support Level $23.25 $3.36
Resistance Level N/A $4.02
Average True Range (ATR) 1.66 0.20
MACD 0.39 0.02
Stochastic Oscillator 99.94 60.17

Price Performance

Historical Comparison
CIX
RCKT

About CIX CompX International Inc.

Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's reportable operating segment includes Security Products and Marine Components. It generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: